145 related articles for article (PubMed ID: 12242520)
1. Gastrointestinal mesenchymal tumors - immunophenotypic classification and survival analysis.
Rudolph P; Chiaravalli AM; Pauser U; Oschlies I; Hillemanns M; Gobbo M; Marichal M; Eusebi V; Höfler H; Capella C; Klöppel G
Virchows Arch; 2002 Sep; 441(3):238-48. PubMed ID: 12242520
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT).
Miettinen M; Sobin LH; Sarlomo-Rikala M
Mod Pathol; 2000 Oct; 13(10):1134-42. PubMed ID: 11048809
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.
Can B; Sökmensüer C
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191
[TBL] [Abstract][Full Text] [Related]
4. Histopathological features and clinical course of the gastrointestinal stromal tumors.
Di Matteo G; Pescarmona E; Peparini N; Di Matteo FM; Zeri KP; Mascagni D; Mele R; Maturo A; Redler A; De Antoni E
Hepatogastroenterology; 2002; 49(46):1013-6. PubMed ID: 12143190
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal stromal tumours.
Miettinen M; Sarlomo-Rikala M; Lasota J
Ann Chir Gynaecol; 1998; 87(4):278-81. PubMed ID: 9891765
[TBL] [Abstract][Full Text] [Related]
6. Extragastrointestinal (soft tissue) stromal tumors: an analysis of 48 cases with emphasis on histologic predictors of outcome.
Reith JD; Goldblum JR; Lyles RH; Weiss SW
Mod Pathol; 2000 May; 13(5):577-85. PubMed ID: 10824931
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal tumors of muscularis mucosae of colon and rectum are benign leiomyomas that should be separated from gastrointestinal stromal tumors--a clinicopathologic and immunohistochemical study of eighty-eight cases.
Miettinen M; Sarlomo-Rikala M; Sobin LH
Mod Pathol; 2001 Oct; 14(10):950-6. PubMed ID: 11598163
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal stromal tumors with internal tandem duplications in 3' end of KIT juxtamembrane domain occur predominantly in stomach and generally seem to have a favorable course.
Lasota J; Dansonka-Mieszkowska A; Stachura T; Schneider-Stock R; Kallajoki M; Steigen SE; Sarlomo-Rikala M; Boltze C; Kordek R; Roessner A; Stachura J; Miettinen M
Mod Pathol; 2003 Dec; 16(12):1257-64. PubMed ID: 14681327
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics.
Miettinen M; Lasota J
Pol J Pathol; 2003; 54(1):3-24. PubMed ID: 12817876
[TBL] [Abstract][Full Text] [Related]
10. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34.
Sarlomo-Rikala M; Kovatich AJ; Barusevicius A; Miettinen M
Mod Pathol; 1998 Aug; 11(8):728-34. PubMed ID: 9720500
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic study of 275 cases of gastrointestinal stromal tumors: the experience at 3 large medical centers in Mexico.
Alvarado-Cabrero I; Vázquez G; Sierra Santiesteban FI; Hernández-Hernández DM; Pompa AZ
Ann Diagn Pathol; 2007 Feb; 11(1):39-45. PubMed ID: 17240306
[TBL] [Abstract][Full Text] [Related]
12. Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylate.
Chirieac LR; Trent JC; Steinert DM; Choi H; Yang Y; Zhang J; Patel SR; Benjamin RS; Raymond AK
Cancer; 2006 Nov; 107(9):2237-44. PubMed ID: 16998931
[TBL] [Abstract][Full Text] [Related]
13. Biological analysis of gastrointestinal stromal tumors.
Noguchi T; Sato T; Takeno S; Uchida Y; Kashima K; Yokoyama S; Müller W
Oncol Rep; 2002; 9(6):1277-82. PubMed ID: 12375034
[TBL] [Abstract][Full Text] [Related]
14. Characterization of GIST/GIPACT tumors by inmunohistochemistry and exon 11 analysis of c-kit by PCR.
Bernet L; Zuñiga A; Cano R
Rev Esp Enferm Dig; 2003 Oct; 95(10):688-91, 683-7. PubMed ID: 14588063
[TBL] [Abstract][Full Text] [Related]
15. [Immunohistochemical and ultrastructural heterogeneity of gastrointestinal stromal tumors].
Handra-Luca A; Nahon P; Fléjou JF; Molas G; Dubois S; Sauvanet A; Belghiti J; Ruszniewski P; Degott C; Terris B
Gastroenterol Clin Biol; 2001; 25(6-7):664-8. PubMed ID: 11673733
[TBL] [Abstract][Full Text] [Related]
16. [Gastrointestinal mesenchymal tumors: a clinical pathologic and immunohistochemical study of 210 cases].
Wang ZQ; Wang S; Ye YJ; Kang YL; Sun KK; Zheng HF
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jan; 10(1):11-6. PubMed ID: 17253165
[TBL] [Abstract][Full Text] [Related]
17. Prognosis of gastrointestinal stromal tumors.
Bertin M; Angriman I; Scarpa M; Mencarelli R; Ranzato R; Ruffolo C; Polese L; Iacobone M; D'Amico DF
Hepatogastroenterology; 2007; 54(73):124-8. PubMed ID: 17419245
[TBL] [Abstract][Full Text] [Related]
18. Prognostic assessment of gastrointestinal stromal tumor.
Yan H; Marchettini P; Acherman YI; Gething SA; Brun E; Sugarbaker PH
Am J Clin Oncol; 2003 Jun; 26(3):221-8. PubMed ID: 12796588
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity.
Debiec-Rychter M; Wasag B; Stul M; De Wever I; Van Oosterom A; Hagemeijer A; Sciot R
J Pathol; 2004 Apr; 202(4):430-8. PubMed ID: 15095270
[TBL] [Abstract][Full Text] [Related]
20. [CD117 contribution in the diagnosic of mesenchymal tumors of the digestive tract].
Khadija B; Saadia B; Ines C; Sami K; Mohamed J; Zina C; Nidhammeddine K; Mohamed MZ; Slim H
Tunis Med; 2005 Nov; 83(11):669-71. PubMed ID: 16422363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
